Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP564330.RAntrU2n7aZ2oxNfkZO14REBh8joNtvI9b4Qyqwc5Z0xs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP564330.RAntrU2n7aZ2oxNfkZO14REBh8joNtvI9b4Qyqwc5Z0xs130_assertion type Assertion NP564330.RAntrU2n7aZ2oxNfkZO14REBh8joNtvI9b4Qyqwc5Z0xs130_head.
- NP564330.RAntrU2n7aZ2oxNfkZO14REBh8joNtvI9b4Qyqwc5Z0xs130_assertion wasGeneratedBy ECO_0000203 NP564330.RAntrU2n7aZ2oxNfkZO14REBh8joNtvI9b4Qyqwc5Z0xs130_provenance.
- NP564330.RAntrU2n7aZ2oxNfkZO14REBh8joNtvI9b4Qyqwc5Z0xs130_assertion wasDerivedFrom befree-20140225 NP564330.RAntrU2n7aZ2oxNfkZO14REBh8joNtvI9b4Qyqwc5Z0xs130_provenance.
- NP564330.RAntrU2n7aZ2oxNfkZO14REBh8joNtvI9b4Qyqwc5Z0xs130_assertion SIO_000772 15314693 NP564330.RAntrU2n7aZ2oxNfkZO14REBh8joNtvI9b4Qyqwc5Z0xs130_provenance.
- NP564330.RAntrU2n7aZ2oxNfkZO14REBh8joNtvI9b4Qyqwc5Z0xs130_assertion evidence source_evidence_literature NP564330.RAntrU2n7aZ2oxNfkZO14REBh8joNtvI9b4Qyqwc5Z0xs130_provenance.
- NP564330.RAntrU2n7aZ2oxNfkZO14REBh8joNtvI9b4Qyqwc5Z0xs130_assertion description "[Our results suggest that (a) deficiency in MIC-NKG2D immune surveillance may contribute to prostate cancer progression, (b) sMIC may be a novel biomarker for prostate cancer, and (c) using cytokines to restore MIC-NKG2D-mediated immunity may have clinical significance for prostate cancer in cell-based adaptive immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP564330.RAntrU2n7aZ2oxNfkZO14REBh8joNtvI9b4Qyqwc5Z0xs130_provenance.